Amaryl satisfaction and usage data | Monitoring more than 6,200 patients | Drug safety information

Amaryl (Glimepiride) - monitoring more than 6,200 patients

Check It Now!

Get your free interaction check for Amaryl by entering your medicines in the boxes below:

(You can add more medicines once you register.)

Your Details

MediGuard is not a substitute for professional medical advice, and that the use of this service is at your own risk. You will always seek the advice of a qualified health provider before making any changes to your treatment.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. MediGuard cannot and does not take into account every possible interaction or account for individual responses to medicine.

Deidentified data collected by MediGuard may be used for research purposes to improve drug safety knowledge. By registering with the MediGuard service, you are agreeing to receive information about research and medical education opportunities that may be relevant to your health and safety.

I agree to MediGuard's terms of service, privacy policy and the above conditions of use.

What does it do?

This product is used in the treatment of diabetes mellitus. It works by stimulating the pancreas to produce more insulin.

Last text update: 2011-10-04

Last data update: 2012-01-14

Usage:

Amaryl is most commonly used to treat the conditions below, together with the percentage of all people taking the medication for the particular condition.

Diabetes

100%

General Information:

6.2: Amaryl Average Satisfaction Score

72% of patients are at least somewhat satisfied with Amaryl.
19% of patients wish they were told more before they started taking Amaryl

MediGuard regularly polls our more than 6,200 users taking Amaryl (or similar drugs with the same active ingredient(s)) using the Treatment Satisfaction Questionnaire for Medications (TSQM). This feedback is continuously updated for the benefit of the MediGuard community. To request scores for specific patient subgroups, please contact research@mediguard.org.

Comments

Global Patient Feedback for Amaryl (Glimepiride)

Please see our forum guidelines.